Operation Warp Speed releases playbook for COVID-19 therapeutics

Operation Warp Speed released a playbook to assist providers in planning to allocate and distribute soon-to-be-available COVID-19 therapeutics. The Food and Drug Administration is expected to issue emergency use authorizations for at least two monoclonal antibody therapeutic drugs developed to treat some COVID-19 patients in the near future. The initial playbook focuses on drug delivery via infusion and those outpatient settings where infusions are delivered. The document will evolve as other treatments and administration methods become available.